JAMA study questions antidepressant efficacy in patients with less severe disease
This article was originally published in Scrip
A meta-analysis published online in the Journal of the American Medical Association has cast doubt over the effectiveness of antidepressants in patients with mild, moderate forms, and some severe forms, of acute depression.
You may also be interested in...
Somaxon Pharmaceuticals and Procter & Gamble Pharmaceuticals are to co-promote Somaxon's insomnia drug Silenor (low-dose doxepin) in the US.
GlaxoSmithKline has begun the Phase III clinical trials programme for its adjuvanted vaccine candidate (GSK1437173A) against herpes zoster for the prevention of shingles.
The EMA has accepted Optimer Pharmaceuticals' MAA for its narrow-spectrum antibiotic fidaxomicin for the treatment of Clostridium difficile infection (CDI) and for the prevention of recurrences of CDI.